|Day Low/High||116.26 / 120.17|
|52 Wk Low/High||59.51 / 176.50|
Jim Cramer weighs in on Bank of America, YY, Okta, Sarepta Therapeutics, Wendy's, ADT, New Residential Investment, First Interstate Bancshares and more.
On the 14th anniversary for 'Mad Money', Jim Cramer talks about how to balance owning index funds and individual stocks.
Luck is our constant companion in the stock market and we are fools if we ignore that fact.
Can they finally put some points on the board?
Shares of Sarepta Therapeutics surge after the company announces an early stage study of a gene-therapy treatment that could benefit patients with a rare form of muscular dystrophy shows promising results.
Jim Cramer asks whether there aren't enough good things happening that we can sustain an advance without a China deal.
Jim Cramer takes a look at Cisco Systems, Deutsche Bank, CVS, Trimble Navigation, Sarepta Therapeutics, Foot Locker, Nike and more.
If this stock breaks through resistance, we could see a powerful run towards the $200 area.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Sarepta Therapeutics Inc , where a total volume of 4,094 contracts has been traded thus far today, a contract volume which is representative of approximately 409,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 43.7% of SRPT's average daily trading volume over the past month, of 937,745 shares.
Stick to your methodology and don't let worry of underperformance push you to shift your approach.
There are obvious signs that people are trying to put cash to work.
After two chaotic days, Wall Street is trading relatively calmly, creating opportunities for individual names to show life.
CEOs of the top 350 companies, the average compensation was $18.9 million annually. So, who were the highest paid executives? Watch the video.
The CEOs who bring in the most money every year may not be who you expect. Who are the highest-paid CEOs?
Walmart -- with great growth -- sparks optimism, but Jim Cramer says it's not the only stock to fuel the day's rally.
Jim Cramer weighs in on Sony, United Rentals, Marathon Petroleum, Royal Dutch Shell, Lam Research, NuStar Energy, Ebix and more.
Small and mid-cap biotech firms are driving innovation in the sector. Experts explain why investors should take notice.
This is a battleground stock that has made big moves in both directions on earnings in the past.
The pressure on financials is affecting the entire market.
If you are interested in Square longer term be patient and wait for the drama to end.
The stock still needs to do more work to be convincing.
I'm not yet convinced that this poor action is the start of a major change in market character.
Blue chip name PEP is a good example of the weak action in individual stocks.
It's an interesting story but there are better places for your funds.
This options trade gives the position plenty of time to work.
Traders are likely remembering what Facebook stock did when Mark Zuckerberg testified before Congress.
It is the poster boy for the havoc that internet retailers have wrecked on brick and mortar retailers.
The indices are being jerked around on some news headlines today.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.